First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of ...

The devices segment, which includes MRI-ultrasound fusion systems ... of healthcare providers with its use. Fusion biopsy is primarily used for prostate cancer diagnosis, although it also has ...

and improving the management of prostate cancer, especially for patients undergoing active surveillance. The fusion biopsy market is divided into two main categories: devices and accessories. The ...

In this manufacturer-sponsored, prospective, multicenter trial, investigators evaluated the efficacy of magnetic resonance imaging (MRI)-guided focused ultrasound for the treatment of leiomyomas ...

To address these issues, the team investigated whether MRI could reliably guide biopsy decisions. The authors explained that they “wanted to determine if men with suspected prostate cancer but normal ...

The global fusion biopsy ... with real-time ultrasound for precise targeting of suspicious lesions. The demand for these equipment is fueled by the increasing prevalence of prostate cancer ...

Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Fusion Biopsy Market ... imaging with real-time ultrasound for precise targeting of suspicious lesions. The demand for these equipment is fueled by the ...

Fusion Biopsy market is estimated to be valued at USD 791.1 Mn in 2025 and is expected to reach USD 1,418.2 Mn by 2032 exhibiting a CAGR of 8.7% from 2025-2032. Rising prostate cancer cases drive ...

Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Fusion Biopsy ... ultrasound for precise targeting of suspicious lesions. The demand for these equipment is fueled by the increasing prevalence of ...

MRI scanning and biopsy could reduce delays in the correct treatment for bladder cancer by more than six weeks. ScienceDaily . Retrieved February 5, 2025 from www.sciencedaily.com / releases ...